WIM
RDY icon

Westside Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Westside Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.6K Sell
4,595
-55
-1% -$742 0.01% 519
2026
Q1 		$62K Hold
4,650
– – 0.01% 515
2025
Q4 		$64.5K Buy
4,650
+55
+1% +$771 0.01% 480
2025
Q3 		$65.2K Buy
4,595
+2,236
+95% +$32.2K 0.01% 478
2025
Q2 		$35.2K Buy
+2,359
New +$33.7K 0.01% 521

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Westside Investment Management's RDY Position: Q2 2026 in Review

Westside Investment Management reduced its Dr. Reddy's Laboratories (RDY) stake by 1.2% in Q2 2026, selling an estimated $742 and leaving 4,595 shares worth $66.6K. The position accounts for 0.01% of the portfolio, ranked #519.

Westside Investment Management first reported a position in RDY in Q2 2025 and has held it in 5 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Westside Investment Management held 4,595 shares of Dr. Reddy's Laboratories worth $66.6K as of Q2 2026.
  • Westside Investment Management sold 55 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $742.
  • Dr. Reddy's Laboratories made up 0.01% of Westside Investment Management's portfolio in Q2 2026, its #519 holding.
  • Westside Investment Management first reported a position in Dr. Reddy's Laboratories in Q2 2025 and has held it in 5 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.